Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study

Documenti analoghi

• Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
  di: Yu Peng, et al.
  Pubblicazione: (2025)
• Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
  di: Claudio Maffeis, et al.
  Pubblicazione: (2024)
• Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes
  di: Chloë Aernouts, et al.
  Pubblicazione: (2024)
• Food insecurity is a risk factor for metabolic dysfunction‐associated steatotic liver disease in Latinx children
  di: Sarah L. Maxwell, et al.
  Pubblicazione: (2024)
• An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
  di: Zhuolin Zhou, et al.
  Pubblicazione: (2025)